Stay updated with breaking news from Cardiovascular Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health.
Four Ethiopian children had open-heart surgery this month at the Jayadeva Institute of Cardiovascular Sciences, a press release from the hospital said. The children from the East African country approached the hospital after having waited for years for foreign surgery teams to arrive at its capital, Addis Ababa. While the city has some facilities for open heart surgery, it
Karnataka: To serve over 12 lakh residents of the district of Chikkaballapur and the surrounding areas, the Sri Sathya Sai Sanjeevani Centres for Heart Care has commenced its fifth centre. To resolve the issue of accessibility and affordability of cardiac treatment, Sadguru Sri Madhusudan Sai, Founder of the global chain of the Sri Sathya Sai Sanjeevani Centres for Cardiac
A new study examined whether high-density lipoprotein cholesterol offered health benefits against cardiovascular events. The study compared health records between two race groups.
A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK. With the signing of a partnership between the University of Birmingham and Acticor Biotech, a new clinical trial called LIBERATE will take place in two acute care hospitals in the UK: the Queen Elizabeth ...